DiaMedica Therapeutics shareholders approve articles amendments and elect directors at annual meeting

At an Annual General and Special Meeting of Shareholders held on May 17, 2023, the shareholders of DiaMedica Therapeutics Inc. (the “Company”) approved two amendments to the Company’s Articles (collectively, the “Articles Amendments”), one of which enhanced the procedural mechanics and disclosure requirements relating to director nominations made by the Company’s shareholders in order to make reference to the universal proxy rules of the U.S. Securities and Exchange Commission (the “SEC”), ensure an orderly nomination and election process, and ensure that a dissident’s interests are fully disclosed to the Company and its shareholders, and the other which provided that only the Board of Directors (the “Board”) may fix the number of directors of the Company.

Voting Proposal One - Election of Directors. The six director nominees proposed by the Board were elected to serve as members of the Board until the next annual general meeting of shareholders and until their respective successors are duly elected and qualified by the following final voting results: Votes For Votes Withheld Broker Non-Votes Richard Pilnik 4,574,007 357,427 8,408,839 Michael Giuffre, M.D. 4,665,154 266,280 8,408,839 Tanya Lewis 4,627,912 303,522 8,408,839 James Parsons 4,673,229 258,205 8,408,839 Rick Pauls 4,658,601 272,833 8,408,839 Charles Semba, M.D. 4,678,225 253,209 8,408,839

Voting Proposal Three – Approval of Amendment to Articles Regarding Director Nominations by Shareholders. The voting proposal to approve an amendment to the Company’s Articles regarding director nominations by shareholders was approved by the following final voting results: Votes For Votes Against Broker Non-Votes 4,520,227 411,207 8,408,839

Voting Proposal Four – Approval of Amendment to Articles Regarding Board Authority to Fix Number of Directors. The voting proposal to approve an amendment to the Company’s Articles regarding the Board’s authority to fix the number of directors was approved by the following final voting results: Votes For Votes Against Broker Non-Votes 3,403,969 1,527,464 8,408,839

Voting Proposal Two - Appointment of Independent Registered Public Accounting Firm and Authorization to Fix Remuneration. The voting proposal to appoint Baker Tilly US, LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2023 and authorize the Board to fix the Company’s independent registered public accounting firm’s remuneration was approved by the following final voting results: Votes For Votes Withheld Broker Non-Votes 13,051,215 289,058 0